Publications: MRS Katila George
Dobson R
(
2023
)
.
A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis
.
Multiple Sclerosis Journal
Dobson R
(
2023
)
.
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
.
Multiple Sclerosis Journal
Jacobs BM, Schalk L, Dunne A, Scalfari A, Nandoskar A, Gran B, Mein CA, Sellers C et al.
(
2023
)
.
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK
.
BMJ Open
vol.
13
,
(
5
)
Tallantyre E, Vickaryous N, Richards A, Rios F, George K, Scurr M, Loveless S
(
2022
)
.
T-cell response following COVID booster vaccination in seronegative people with multiple sclerosis
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
93
,
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al.
(
2022
)
.
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
64
,
Dobson R
(
2022
)
.
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
.
Multiple Sclerosis and Related Disorders
Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G
(
2021
)
.
COVID-19 vaccine response in people with multiple sclerosis
.
Annals of Neurology
Dobson R, Holden D, Vickaryous N, Bestwick J, George K, Sayali T, Bianchi L, Wafa M et al.
.
A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis
.
Tallantyre EC, Vickaryous N, Anderson V, Asardag AN, Baker D, Bestwick J, Bramhall K, Chance R et al.
.
COVID-19 vaccine response in people with multiple sclerosis
.
Jacobs BM, Schalk L, Tregaskis-Daniels E, Scalfari A, Nandoskar A, Dunne A, Gran B, Mein CA et al.
.
Genetic determinants of Multiple Sclerosis susceptibility in diverse ancestral backgrounds
.
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al.
.
Response to COVID-19 booster vaccinations in seronegative people with MS
.